Partnering
With its strong proprietary technology position, including a broad basis of preclinical data, XL-protein focuses at the preclinical as well clinical development of PASylated proteins in several disease areas. To uncover the full potential of the PASylation technology XL-protein offers licensing opportunities on several levels.